Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype. | Front Cell Dev Biol | 2023 | 37215087 | PubTator, text mining | PubMed |
| New insights into the ambivalent role of YAP/TAZ in human cancers. | J Exp Clin Cancer Res | 2023 | 37211598 | PubTator, text mining | PubMed |
| PLCB1 Enhances Cell Migration and Invasion in Gastric Cancer Via Regulating Actin Cytoskeletal Remodeling and Epithelial-Mesenchymal Transition. | Biochem Genet | 2023 | 37208557 | PubTator, text mining | PubMed |
| Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho-ROCK-mediated contractility dependent. | Bioeng Transl Med | 2023 | 37206242 | PubTator, text mining | PubMed |
| Molecular mechanisms involved in regulating protein activity and biological function of MST3. | Cell Div | 2023 | 37202821 | PubTator, text mining | PubMed |
| HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1. | Cell Death Dis | 2023 | 37193711 | PubTator, text mining | PubMed |
| Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer. | Cancers (Basel) | 2023 | 37190165 | PubTator, text mining | PubMed |
| IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium. | Cells | 2023 | 37190063 | PubTator, text mining | PubMed |
| Spatiotemporal Cofilin Signaling, Microglial Activation, Neuroinflammation, and Cognitive Impairment Following Hemorrhagic Brain Injury. | Cells | 2023 | 37190062 | PubTator, text mining | PubMed |
| Diagnostic Value of Chromosomal Microarray Analysis for Fetal Congenital Heart Defects with Different Cardiac Phenotypes and Extracardiac Abnormalities. | Diagnostics (Basel) | 2023 | 37189594 | PubTator, text mining | PubMed |
| CD73 mediated host purinergic metabolism in intestine contributes to the therapeutic efficacy of a novel mesenchymal-like endometrial regenerative cells against experimental colitis. | Front Immunol | 2023 | 37180168 | PubTator, text mining | PubMed |
| A Descriptive Whole-Genome Transcriptomics Study in a Stem Cell-Based Tool Predicts Multiple Tissue-Specific Beneficial Potential and Molecular Targets of Carnosic Acid. | Int J Mol Sci | 2023 | 37175790 | PubTator, text mining | PubMed |
| Inhibition of airway smooth muscle contraction and proliferation by LIM kinase inhibitor, LIMKi3. | Adv Med Sci | 2023 | 37148787 | PubTator, text mining | PubMed |
| miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma. | Oncogenesis | 2023 | 37147294 | PubTator, text mining | PubMed |
| A CRISPR interference strategy for gene expression silencing in multiple myeloma cell lines. | J Biol Eng | 2023 | 37143063 | PubTator, text mining | PubMed |
| Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth. | Front Physiol | 2023 | 37138671 | PubTator, text mining | PubMed |
| Sanhua decoction: Current understanding of a traditional herbal recipe for stroke. | Front Neurosci | 2023 | 37123364 | PubTator, text mining | PubMed |
| Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges. | Int J Mol Sci | 2023 | 37108446 | PubTator, text mining | PubMed |
| Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. | Ther Adv Cardiovasc Dis | 2023 | 37092838 | PubTator, text mining | PubMed |
| Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma. | Front Pharmacol | 2023 | 37081968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=13